ArticleFrontiers in neurology2022
Evaluation of the non-auditory neurocognitive test MoCA-HI for hearing-impaired.
Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Article
- Montreal Cognitive Assessment Hearing Impairment (MoCA-H) in brazilian portuguese: performance analysis.CoDAS · 2026Observational
- Neuropsychological Assessments to Explore the Cognitive Impact of Cochlear Implants: A Scoping Review.Journal of clinical medicine · 2025Review
- [Assessment of cognition: dementia and delirium : In consideration of the AWMF guidelines 038-013 and 084-002LG].Der Nervenarzt · 2025Article
- Application of mindfulness-based stress reduction plan in post-stroke patients with mild depression.Frontiers in neurology · 2025Article
- [Assessment of cognition: dementia and delirium : In consideration of the AWMF guidelines 038-013 and 084-002LG].Zeitschrift fur Gerontologie und Geriatrie · 2024Article
- Do people with cognitive impairment benefit from cochlear implants? A scoping review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Article
- Hearing loss and cognition: A protocol for ensuring speech understanding before neurocognitive assessment.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Validation of the German Montreal-Cognitive-Assessment-H for hearing-impaired.Frontiers in aging neuroscience · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since hearing loss and cognitive decline often co-occur among older adults, a cognitive screening test suitable for hearing-impaired people is of high clinical relevance. We report the first evaluation of a German language version of the Montreal Cognitive Assessment-Hearing Impaired version (MoCA-HI). Objective: The aim of the present study was to compare cognitively healthy participants with and without hearing loss, to examine the impact of age, sex, educational level and degree of hearing impairment on the German MoCA-HI performance, and to develop normative data. Material and methods: The German MoCA-HI was tested in 94 participants with normal or mild hearing impairment (group 1: 4PTA ≤ 40 dB on the better hearing ear) and 81 participants with moderate to profound hearing loss (group 2: 4PTA > 40 dB on the better hearing ear). Additionally, all participants performed the standard MoCA (version 8.2). Results: No significant group difference between group 1 and 2 was found in the MoCA-HI total score ( Conclusion: The MoCA-HI is a cognitive screening test which is suitable for people with hearing impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.